These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 19864026
1. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death. Gancz D, Donin N, Fishelson Z. Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026 [Abstract] [Full Text] [Related]
2. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons. Fogarty MP, Downer EJ, Campbell V. Biochem J; 2003 May 01; 371(Pt 3):789-98. PubMed ID: 12534344 [Abstract] [Full Text] [Related]
3. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. Eguchi R, Fujimori Y, Takeda H, Tabata C, Ohta T, Kuribayashi K, Fukuoka K, Nakano T. J Cell Physiol; 2011 Mar 01; 226(3):762-8. PubMed ID: 20799280 [Abstract] [Full Text] [Related]
4. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA. Gastroenterology; 2009 Apr 01; 136(4):1423-34. PubMed ID: 19249395 [Abstract] [Full Text] [Related]
5. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation. Yao K, Cho YY, Bergen HR, Madden BJ, Choi BY, Ma WY, Bode AM, Dong Z. Cancer Res; 2007 Sep 15; 67(18):8725-35. PubMed ID: 17875713 [Abstract] [Full Text] [Related]
6. JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells. David S, Hila S, Fosbrink M, Rus H, Koski CL. J Peripher Nerv Syst; 2006 Mar 15; 11(1):77-87. PubMed ID: 16519786 [Abstract] [Full Text] [Related]
7. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oleinik NV, Krupenko NI, Krupenko SA. Oncogene; 2007 Nov 08; 26(51):7222-30. PubMed ID: 17525747 [Abstract] [Full Text] [Related]
8. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. Ma FY, Flanc RS, Tesch GH, Han Y, Atkins RC, Bennett BL, Friedman GC, Fan JH, Nikolic-Paterson DJ. J Am Soc Nephrol; 2007 Feb 08; 18(2):472-84. PubMed ID: 17202416 [Abstract] [Full Text] [Related]
9. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation through regulating cell cycle progression. Zhang D, Li J, Song L, Ouyang W, Gao J, Huang C. Mol Cancer Res; 2008 Jan 08; 6(1):165-74. PubMed ID: 18234971 [Abstract] [Full Text] [Related]
10. SAPKgamma/JNK1 and SAPKalpha/JNK2 mRNA transcripts are expressed in early gestation human placenta and mouse eggs, preimplantation embryos, and trophoblast stem cells. Zhong W, Sun T, Wang QT, Wang Y, Xie Y, Johnson A, Leach R, Puscheck EE, Rappolee DA. Fertil Steril; 2004 Oct 08; 82 Suppl 3():1140-8. PubMed ID: 15474087 [Abstract] [Full Text] [Related]
11. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis. Katagiri C, Negishi K, Hibino T. J Dermatol Sci; 2006 Sep 08; 43(3):171-9. PubMed ID: 16824735 [Abstract] [Full Text] [Related]
12. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury. Ren G, Huynh C, Bijian K, Cybulsky AV. Mol Immunol; 2008 Apr 08; 45(8):2236-46. PubMed ID: 18178252 [Abstract] [Full Text] [Related]
13. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS. J Pharmacol Exp Ther; 2008 Jun 08; 325(3):841-9. PubMed ID: 18337475 [Abstract] [Full Text] [Related]
14. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells. Chen N, She QB, Bode AM, Dong Z. Cancer Res; 2002 Mar 01; 62(5):1300-4. PubMed ID: 11888895 [Abstract] [Full Text] [Related]
15. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1. Nielsen C, Thastrup J, Bøttzauw T, Jäättelä M, Kallunki T. Cancer Res; 2007 Jan 01; 67(1):178-85. PubMed ID: 17210697 [Abstract] [Full Text] [Related]
16. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. Yeap YY, Ng IH, Badrian B, Nguyen TV, Yip YY, Dhillon AS, Mutsaers SE, Silke J, Bogoyevitch MA, Ng DC. Biochem J; 2010 Sep 01; 430(2):345-54. PubMed ID: 20594188 [Abstract] [Full Text] [Related]
17. Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain. Wang Y, Luo W, Reiser G. Biochem J; 2007 Jan 01; 401(1):65-78. PubMed ID: 16942465 [Abstract] [Full Text] [Related]
18. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Zhou JY, Liu Y, Wu GS. Cancer Res; 2006 May 01; 66(9):4888-94. PubMed ID: 16651445 [Abstract] [Full Text] [Related]
19. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Osto E, Matter CM, Kouroedov A, Malinski T, Bachschmid M, Camici GG, Kilic U, Stallmach T, Boren J, Iliceto S, Lüscher TF, Cosentino F. Circulation; 2008 Nov 11; 118(20):2073-80. PubMed ID: 18955669 [Abstract] [Full Text] [Related]